ArticleThoracic cancer2022

Pretreatment body mass index predicts survival among patients administered nivolumab monotherapy for pretreated non-small cell lung cancer.

Hisao Imai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.